Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes.

Gracen, Lucy; Hayward, Kelly L; Aikebuse, Melanie; Russell, Anthony; O'Beirne, James; McPhail, Steven; Irvine, Katharine M; Williams, Suzanne; Valery, Patricia C; Powell, Elizabeth E

Gracen, Lucy; Hayward, Kelly L; Aikebuse, Melanie; Russell, Anthony; O'Beirne, James; McPhail, Steven; Irvine, Katharine M; Williams, Suzanne; Valery, Patricia C; Powell, Elizabeth E.

Afiliação

Gracen L; Centre for Liver Disease Research, Faculty of Medicine, Translational Research Institute, The University of Queensland, Level 5, West Wing, 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.
Hayward KL; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Aikebuse M; Centre for Liver Disease Research, Faculty of Medicine, Translational Research Institute, The University of Queensland, Level 5, West Wing, 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.
Russell A; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
O'Beirne J; Centre for Liver Disease Research, Faculty of Medicine, Translational Research Institute, The University of Queensland, Level 5, West Wing, 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.
McPhail S; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Irvine KM; Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
Williams S; Department of Endocrinology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Valery PC; Department of Gastroenterology and Hepatology, Sunshine Coast University Hospital, Birtinya, QLD, Australia.
Powell EE; Australian Centre for Health Services Innovation School of Public Health, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, QLD, Australia.

BMC Health Serv Res ; 22(1): 487, 2022 Apr 12.

Article em En | MEDLINE | ID: mdl-35413987

Assuntos

Carcinoma Hepatocelular; Diabetes Mellitus Tipo 2; Neoplasias Hepáticas; Hepatopatia Gordurosa não Alcoólica; Carcinoma Hepatocelular/complicações; Procedimentos Clínicos; Diabetes Mellitus Tipo 2/complicações; Diabetes Mellitus Tipo 2/epidemiologia; Diabetes Mellitus Tipo 2/terapia; Fibrose; Humanos; Cirrose Hepática/diagnóstico; Cirrose Hepática/terapia; Neoplasias Hepáticas/complicações; Hepatopatia Gordurosa não Alcoólica/diagnóstico; Hepatopatia Gordurosa não Alcoólica/terapia; Estudos Prospectivos

Palavras-chave

Cirrhosis; Delivery of health care; Diabetes complications; Integrated; Patient care; Risk assessment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: BMC Health Serv Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google